Back to Invesco Ltd. Invesco Ltd.

LGNDLGND
Showing 8 of 23 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in LIGAND PHARMACEUTICALS

Invesco Ltd. holds 1.2M shares of LGND (LIGAND PHARMACEUTICALS), worth $379.8M as of 2026-Q2. The position was increased (+45.9% shares). LGND represents 0.0% of Invesco Ltd.'s portfolio.

Current Value

$379.8M

Current Shares

1.2M

Total Value Change

+$360.9M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+45.9%
$379.8M0.0%$316.09
42
2026-Q1
Increased
823,604
+59.5%
$164.4M0.0%$204.24
44
2025-Q4
Increased
516,464
+36.5%
$97.6M0.0%$190.20
39
2025-Q3
Increased
378,295
+64.6%
$67M0.0%$173.13
43
2025-Q2
Increased
229,858
+13.3%
$26.1M0.0%$114.15
32
2025-Q1
Increased
202,828
+4.4%
$21.3M0.0%$107.62
30
2024-Q4
Increased
194,355
+3.0%
$20.8M0.0%$105.76
29
2024-Q3
Increased
188,728
+9.2%
$18.9M0.0%$97.37
31

Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used